Technology

InsuSense Therapeutics

Technology

InsuSence Therapeutics (IST) is a product-focused biotechnology company modulating the effects of Vps10p in disease.

Our mechanism of action revolves around the Vps10p proteins, a family of proteins that have been implicated in several important human diseases.

The Vps10p domain proteins have intracellular trafficking functions – they move other proteins around the cell from the Golgi, where they are made, to the cell surface and then reinternalize proteins to recycle or lysosomal degradation.